维普期刊资源整合服务平台（V6.5）

123篇 您的检索式：作者名="KARP JE"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Clinical and biologic activity of the arnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias:a phase I clinical-correlative trial显示文摘	Karp JE Lancet JE Kaufmann SH	2001	Blood2001，97，：	1
2	The secondary leukemias: Challenges and research directions 显示文摘	Smith MA McCaffrey RP Karp JE	1996	J Natl Cancer Inst1996，88，7：	1
3	Zarnestra(R115777) in previously untreated poor-risk AML and MDS:preliminary results of a phase Ⅱ trial显示文摘	Lancet JE Karp JE Gotlib J	2002	Blood2002，100，：	1
4	A phase Ⅰ and pharmacologic study of idarubicin cytarabine, etoposide, and the multidrug resistandc protein (MDR1/) inhibitor PSC-833 in patients with refractory leukemia显示文摘	Bauer KS Karp JE Garimella TS	2005	Leuk Res2005，29，3：	1
5	Ribonueleotide reductase:an old target with new potential显示文摘	Karp JE	2003	Leuk Res2003，27，12：	1
6	Active oral regimen for elderly adults with newlydiagnosed acute myelogenous leukemi : a preclinical and phase I trial of the famesyltrausferase inhibitor tipifarnib ( R115777, Zameslra ) combined with etoposide 显示文摘	Karp JE Flatten K Feldman E J	2009	Blood2009，113，20：	1
7	MDR modulation in acute myelogenous leukemia:is it dead?显示文摘		2001	Leukemia2001，15，4：	1
8	Bone formation on two dimensional poly(DL-lactide-co-glycolide) (PLGA) films and dare dimensional PLGA tissue engineering scaffolds in vitro显示文摘	Karp JM Shoichet MS Davies JE		0，，：	1
9	Protein profiling of human postmortem brain using 2-dimensional fluorescence difference gel electrophoresis显示文摘	Swatton Je Prakabaran S Karp NA	2004	Molecular Psychiatry2004，9，2：	1
10	Minimal residual disease in acute myeloid leukaemia显示文摘	Hourigan CS Karp JE	2013	Nat Rev Clin Oneol2013，10，8：	1
11	Rihonueleotide reductase:an old target with new potential显示文摘	Smith BD Karp JE	2003	Leuk Res2003，27，12：	1
12	The NIH human microbiome project显示文摘	NIH HMP Working Group Peterson J Garges S Giovanni M McInnes P Wang L Schloss JA Bonazzi V McEwen JE Wetterstrand KA Deal C Baker CC Di Francesco V Howcroft TK Karp RW Lunsford RD Wellington CR Belachew T Wright M Giblin C David H Mills M Salomon R Mullins C Akolkar B Begg L Davis C Grandison L Humble M Khalsa J Little AR Peavy H Pontzer C Portnoy M Sayre MH Starke-Reed P Zakhari S Read J Watson B Guyer M	2009	Genome Res2009，19，12：	1
13	Exprossion of breast cancer resis- tance protein in blast cells from patients with acute leukemia 显示文摘	Ross DD Karp JE Chen TT	2000	Blood2000，96，1：	1
14	Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias:therapy with sequential 1-beta-d-arabinofuranosylcytosine, mitoxantrone, and bevacizumab 显示文摘	Karp JE Gojo I Pili R	2004	Clin Cancer Res2004，10，11：	1
15	Protein profiling of human postmortem brain using 2-dimensional fluorescence difference gel electrophores is (2-D DIGE)显示文摘	SWATTON JE PRABAKARAN S KARP NA LILLEY KS BAHN S	2004	Mol Psychiatry2004，9，2：	1
16	Expression of breast cancer resistance protein in blast cells from patients with acute leukemia显示文摘	Ross DD Karp JE Chen TF	2000	Blood2000，96，1：	1
17	Proteinprofiling of human postmortem brain using 2-dimensionalfluorescence difference gel electrophoresis(2D-DIGE)显示文摘	Swatton JE Prabakaran S Karp NA	2004	Mol Psychiatry2004，9，2：	1
18	Successful treatment of thoracolumbar fractures with short-segment pedicle instrumentation显示文摘	Gelb O Ludwig S Karp JE	2010	J Spinal Disord Tech2010，23，5：	1
19	Successful treatment of thoracolumbar fractures with short-segment pedicle instrume-ntation显示文摘	Gelb D Ludwig S Karp JE		0，，05：	1
20	Expression of breast cancer resitance protein blast cells fron petients with alute leukemia显示文摘	Karp JE Chen TT	2000	Blood2000，96，1：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示